Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
8 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06726317 | Early Palliative Care For Patients With Oral Cancer in Sri Lanka | completed | N/A | 110 | University of ColomboOTHER | 1 | Dec 10, 2024 | clinicaltrials |
| NCT06711848 | Testing and Comparing the Impacts of Mhealth-Based and Web-Based Education on Oral Cancer | not yet recruiting | N/A | 75 | University of RwandaOTHER | 4 | Dec 2, 2024 | clinicaltrials |
| NCT00565708 |
| Aspirin for Dukes C and High Risk Dukes B Colorectal Cancers(ASCOLT) |
| unknown |
| Phase 3 |
| 1,587 |
| National Cancer Centre, SingaporeOTHER |
| 10 |
| Feb 2, 2024 |
| clinicaltrials |
| NCT02778295 | Biomarker for Patients With Fabry Disease (BioFabry)(BioFabry) | withdrawn | — | 0 | CENTOGENE GmbH RostockINDUSTRY | 3 | Feb 13, 2023 | clinicaltrials |
| NCT02654340 | Biomarkers for Tuberous Sclerosis Complex (BioTuScCom)(TuScCom) | terminated | — | 20 | CENTOGENE GmbH RostockINDUSTRY | 8 | Feb 10, 2023 | clinicaltrials |
| NCT01265849 | Efficacy and Safety Study of Leukocyte Interleukin,Injection (LI) to Treat Cancer of the Oral Cavity(IT-MATTERS) | completed | Phase 3 | 928 | CEL-SCI CorporationINDUSTRY | 23 | Aug 19, 2022 | clinicaltrials |
| NCT01125566 | LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment | completed | Phase 3 | 508 | Boehringer IngelheimINDUSTRY | 38 | Jul 18, 2019 | clinicaltrials |
| NCT00476580 | Health Habits and Cancer Risk Comparison Among Migrant Sri Lankans and Sri Lankans | withdrawn | — | 0 | M.D. Anderson Cancer CenterOTHER | 2 | Aug 28, 2015 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials